CRXTClarus:宣布JATENZO®口服睾酮替代疗法的两项新专利标的公司:Clarus Therapeutics Holdings,Inc.(Nasdaq:CRXT) Clarus Therapeutics Holdings,Inc.(CRXT)宣布美国专利商标局(USPTO)批准两项口服睾酮替代产品JATENZO (testosterone undecanoate)相关专利. 专利号11179403:Oral Test...赞 (0)美股订阅2021-12-01阅读(123)